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Abstract 
Background: The WHO recommends that all suspect malaria cases be tested before receiving treatment. Rapid 
diagnostic tests (RDT) for malaria can be performed reliably by community health workers with no formal medical 
background and thus, RDTs could also be provided to travellers for self-diagnosis during visits to endemic regions.
Methods: RDTs were proposed during pre-travel consultations to pre-defined categories of travellers. A training run 
on their own blood was performed and, if carried out correctly, the traveller was given a written procedure on how 
to perform the test and act on its result. The travellers were then proposed to buy a malaria RDT kit and were inter-
viewed upon their return.
Results: From February 2012 to February 2017, 744 travellers were proposed RDTs and 692 performed the training 
run (one could not complete it due to a hand tremor). Among the 691 subjects included, 69% travelled to moderate- 
or low-risk areas of malaria, 18% to high-risk areas and 13% to mixed-risk areas. The two most frequent categories of 
travellers to whom RDTs were proposed were long-term travellers (69%) and those travelling to remote areas (57%). 
543 travellers (79%) were interviewed upon return. During their trip, 17% (91/543) had a medical problem with fever 
and 12% (65/543) without fever. Among 91 febrile patients, 57% (52/91) performed an RDT, 22% (20/91) consulted 
immediately without using the test, and 21% (19/91) did neither. Four RDTs (4/52; 8%) were positive: 2 in low-risk and 
2 in high-risk areas (0.7% attack rate of self-documented malaria). Two travellers could not perform the test correctly 
and attended a facility or took standby emergency treatment. Four travellers with negative results repeated the test 
after 24 h; all were still negative. Carrying RDTs made travellers feel more secure, especially when travelling with 
children.
Conclusions: 1/6 travellers experienced fever and 4/5 of those reacted appropriately: more than half used RDTs and 
a quarter consulted immediately. Four travellers (including 2 from low-risk areas) diagnosed themselves with malaria 
and self-treated successfully. This strategy allows prompt treatment for malaria in high-risk groups and may avoid 
over-diagnosis (and subsequent inappropriate treatment) of malaria on-site.
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Background
Before prescribing anti-malarial therapy in any setting, 
the WHO recommends a confirmation of parasitaemia 
by microscopy or malaria antigen-detecting immuno-
chromatographic rapid diagnostic test (RDT) [1]. Early, 
accurate diagnosis of malaria is also key to prompt treat-
ment which is especially important among non-immune 
travellers to endemic countries, who often suffer more 
severe complications [2]. A meta-analysis of RDTs 
for Plasmodium falciparum among travellers in 2005 
reported 88–99% sensitivity and 95–100% specificity 
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compared to microscopy, with an excellent negative like-
lihood ratio (0.05) [3]. Recent studies in non-endemic 
and endemic settings using PCR as reference test showed 
that sensitivity of RDTs is even higher than standard (but 
not necessarily expert) microscopy [4].
The use of RDTs by travellers has been controversial. 
In 1999, Trachsler et al. reported that a high proportion 
(14%) of travellers in a pre-travel setting was not able to 
interpret dipstick RDTs correctly despite receiving writ-
ten instructions and/or oral explanations. The authors 
thus proposed to perform a training run [5]. Funk et al. 
reported high levels of false-negative interpretation by 
travellers with  MalaQuick® and ParaSight  F® despite 
an information leaflet [6]. In the same year, Jelinek et al. 
showed that 31% of febrile travellers in Kenya failed to 
perform the dipstick test [7]. Self-testing by ill travellers 
has also been studied by Whitty et al. with 9% of travel-
lers not being able to obtain a valid result; they concluded 
that clearer instructions were essential [8].
On the other hand, several studies have now shown 
that, with appropriate instructions, RDTs could be used 
reliably by persons without formal medical training, such 
as oil field employees [9] and community health work-
ers [10]. In an extensive review on the use of RDT in 
travel medicine, Maltha et  al. concluded that RDTs for 
self-diagnosis may be useful for the traveller when com-
prehensive instructions and a training programme are 
guaranteed, but that further studies were needed under 
field settings [11].
The primary aim of this study was to explore the use 
of RDTs for self-diagnosis among selected travellers after 
being provided with practical, oral and written instruc-
tions during a pre-travel consultation. A second objective 
was to investigate whether these travellers would con-
sider taking RDTs again for another similar trip.
Methods
The protocol was approved by the ethics review board of 
the University of Lausanne, Switzerland. The study was 
conducted at the Travel Clinic of the University hospital 
of Lausanne from February 2012 to February 2017. RDTs 
were primarily proposed to travellers planning to visit 
moderate- or low-risk malaria areas (i.e. to whom the 
Swiss guidelines on malaria prevention [12] recommend 
the use of standby emergency treatment (SBET) rather 
than chemoprophylaxis). Categories of adult travellers 
likely to benefit most from carrying RDTs were selected 
as those at higher risk of not having access to rapid/
accurate diagnosis on-site, and those known to under-
use personal protective measures and to poorly adhere 
to recommendations [13–15], namely chemoprophylaxis 
[16]). These categories were: (a) humanitarian workers, 
(b) short-stay frequent travellers (≥ 3 trips of ≤ 7 days/
year), (c) long-term travellers (> 3 months), (d) travellers 
to remote areas (> 24 h delay to access medical care), (e) 
travellers not willing to take malaria chemoprophylaxis 
although recommended by the Swiss guidelines. Health 
care professionals were also included because of their 
potential ability to perform tests as well as travellers will-
ing to take the test even if not belonging to one of the 
above-mentioned categories.
Travellers attending pre-travel consultation and per-
taining to one of these categories were proposed to par-
ticipate in the study. Demographic data were recorded. 
At the end of the pre-travel consultation, and if they 
had given consent, travellers were explained how to 
perform the test using graphic and written instructions 
that detailed the procedure (see Additional file  1). The 
traveller’s ability to perform the test on her/himself 
(including a real finger-prick blood draw) was assessed 
in front of the health professional. If this training run 
using their blood was done correctly, travellers were 
asked to look at pictures of positive, negative and 
invalid tests and to interpret the results. Oral instruc-
tion was then given on how they should react in case 
of febrile illness (≥ 37.5 °C axillary temperature or clear 
subjective sensation of fever) during the trip. If there 
was no possibility to attend a medical facility within 
24 h, they were told to perform an RDT. In case of posi-
tive test, they were recommended to immediately take 
SBET using artemether/lumefantrine or atovaquone/
proguanil, and to seek medical advice to exclude severe 
malaria. In case of a negative result, they were told to go 
to a health facility to look for an alternate diagnosis, and 
to repeat the RDT after 24 h if fever persisted (in order 
not to miss the beginning of a malaria episode with low 
parasite density), as has been recommended and proven 
safe for febrile travellers returning from the tropics [17]. 
In case of an invalid result, they were told to repeat 
the test immediately using a new cassette. Travellers 
were finally provided with a prescription for a kit of 2 
RDTs and related material and for a SBET. The test pro-
posed was the rapid antigen capture assay ICT  Combo® 
 ML02® (ICT Diagnostics, South Africa) up to July 2015 
and then, due to procurement constraints, SD  Bioline® 
Pf/Pan®. Both tests showed an adequate panel detection 
score (PDS) for P. falciparum in the WHO Round 5 of 
Product Testing of Malaria RDTs [18]. Tests combining 
HRP and a panmalarial antigen detection were used so 
that P. vivax could also be detected and to overcome the 
problem of HRP2 deletion found in some regions [19]. 
From December 2014, the pipette included in the ICT 
Combo  test® was changed for an inverted cup because 
a difficulty in transferring blood to the device had been 
noticed. The SD  Bioline® contained an inverted cup. 
The 2 RDTs kit cost 20 Swiss francs.
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Upon return, travellers were contacted via phone or 
email by a study nurse who recorded detailed infor-
mation on destinations and dates of the trip, medi-
cal issues arising during the trip, use of the purchased 
RDTs and the traveller’s wish to take RDTs again for 
another, similar trip. If used, the results of the RDT 
were also recorded along with information on difficul-
ties in performing the test, and the traveller’s reaction 
to the result (such as seeking on-site consultation). All 
data were collected in Microsoft Excel and analyzed 
using Stata (version 14). A traveller was considered to 
have had a malaria episode if they had had a feeling of 
fever and/or an elevated temperature and a positive 
RDT result.
Results
Between February 2012 and February 2017 RDTs were 
proposed to 744 travellers. Reasons for refusal were 
recorded during a period of 2 years (between 01.02.2013 
and 28.02.2015) during which 479 travellers were seen. 
The main reasons among the 52/479 (11%) who were not 
interested in taking RDTs were the preference of attend-
ing a medical facility on-site in case of fever, and a reluc-
tance to prick themselves (Table 1).
692 travellers were enrolled and performed the train-
ing run (Fig. 1). One traveller failed to perform the train-
ing run because of shaking hands. 691 travellers were 
thus followed for evaluation. Median age of travellers 
was 33  years (range 20  months to 74  years); 54% were 
females. 69% were travelling to malaria moderate- to low-
risk areas, 18% to high-risk and 13% to both. The catego-
ries of travellers to whom RDT were proposed are shown 
in Table 2. 
Data on the actual use of RDT during the trip was 
available for 543 travellers who could be interviewed 
upon return (78%). Of the 148 who were not interviewed, 
6 had their trip cancelled, 100 were lost to follow-up and 
42 were still travelling at the time the study ended. The 
median length of stay abroad was 18 weeks (range 5 days 
to 4 years). 71% had travelled to a moderate- or low-risk 
area, 20% to a high-risk area and 9% to destinations 
including both types of risk areas. 71% (387/543) had 
no medical problem during their trip; 17% (91/543) had 
a medical problem with fever, and 12% (65/543) without 
fever.
Among the 91 febrile travellers, 64% had travelled to a 
moderate- or low-risk area. Seventy-two of those (79%) 
strictly followed the recommendations provided in the 
written procedure: 52 (57%) performed an RDT (on a 
traveller’s child in 7 cases and on a febrile relative or 
friend in 6 cases), and 20 (22%) decided to directly attend 
a health facility, and thus, did not use the RDT. Diagnoses 
assigned to those attending health facilities were: diar-
rhoea (11), typhoid fever or salmonellosis (2), ORL infec-
tion (2), dengue fever (1), pneumonia (1), cellulitis (1), 
urinary tract infection (1); one was diagnosed as malaria. 
This female traveller attended an outpatient clinic in 
the Democratic Republic of Congo on the first day of 
her fever, where a rapid diagnostic test (provided by the 
clinic) and a blood slide were negative. Two days later 
she attended again and both were positive with 3% para-
sitaemia. She recovered after quinine and artemether-
lumefantrine treatment. The traveller had stopped her 
prophylaxis of doxycycline 2 months prior to this episode 
following recommendations of fellow expats.
Nineteen travellers (20%) neither used their RDTs 
nor sought medical advice, because of concurrent tran-
sient diarrhoea (17) providing an alternate diagnosis or 
because the duration of fever was limited to a few hours 
(2). Among the 52 febrile travellers who performed 
RDTs, 4 (8%) had a positive result; 2 among travellers to 
low-risk areas (Haiti and Indonesia) and 2 to high-risk 
areas (Southern Sudan and Cameroon). All four malaria 
cases took adequate SBET and recovered. One attended 
a local clinic thereafter, while the 3 others did not. 
Among those, one was unsure about the result because 
he saw a faint line but took the SBET as instructed. He 
repeated the test after 24  h and found again a positive 
result.
Fifty-one RDT results were negative among 21 travel-
lers to high-risk and 30 to moderate- to low-risk areas. 
6 were performed in non-febrile travellers. Fifteen travel-
lers sought medical advice afterwards while 36 did not. 
Four travellers repeated the test after 24 h, and the result 
was, again, negative. The others did not because they 
were fever-free by that time. One test was invalid; the test 
was immediately repeated and the result was negative. 
In two cases, the test was not properly performed. One 
traveller to Ecuador read the result after several hours 
because he had fallen asleep. As the test seemed posi-
tive, he immediately went to hospital, where he presented 
with no fever and was sent back home with neither test 
nor treatment. On the following day he attended a clinic 
Table 1 Reasons mentioned by  travellers for  not being 
interested in taking RDTs
Reasons for not being interested to take RDTs 
(multiple entries possible)
Total N = 52 (%)
Sufficient accessibility to on-site medical care 24 (46)
Reluctance to prick themselves 20 (38)
No interest, useless measure 11 (21)
Insufficient money to buy the test 8 (15)
Reluctance to carry the test 3 (6)
Risk too low to justify measure 2 (4)
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691
included (bought RDTs) 
42 still on travel
6 cancelled their trip 
643
returned from their trip
100 lost to follow up
543
were interviewed upon return
744
travellers were proposed RDT
1 failed to perform RDT
692
performed the blank run
91
had fever during the trip
65
were sick without fever
387 had no medical problem
52
performed RDT
20
consulted
19
did neither
6
performed RDT
4
positive 
RDT
1
invalid
RDT
2
RDT not 
well
performed
45
negative
RDT
6
negative
RDT
4
took
SBET
4
repeated
RDT
after 24 hours
16
consulted
1
repeated
RDT
immediately
1
took
SBET
52/479 (11%) travellers were
not interested between
01.02.13 and 28.02.15
From 01.02.2012 to 28.02.2017
Fig. 1 Flowchart of travellers included in the study
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specialized in malaria because of headache. A rapid diag-
nostic test was negative and the traveller left without 
anti-malarial drugs. Another traveller in Cameroon had 
lost the instruction leaflet and had difficulty transferring 
blood to the device. As he was not sure how to interpret 
the result, he decided to take the SBET.
When asked upon return, 90% (488/543) of the travel-
lers stated that they would take RDTs again for a future, 
similar trip while 10% (55/543) would not, without sta-
tistically significant difference between those who had 
fever or not during their trip (11 and 10% respectively; 
p = 0.725) or those having used a RDT or not (9 and 10% 
respectively; p = 0.714).
The reasons for intending to take or not take RDT for a 
future trip are presented in Table 3.
Discussion
One out of six travellers (16.7%) experienced fever dur-
ing their trip, which is much higher than the 3% reported 
among the average American traveller [20]. Most of 
these febrile travellers (4 out of 5) reacted properly by 
either performing an RDT (more than half ), or attend-
ing a health facility (almost a quarter). This rate is satis-
factory, comparing to previous studies. For example, in 
1995, Schlagenhauf et al. reported that 2 out of 3 travel-
lers to low-risk areas, who had received pre-travel advice, 
failed to seek prompt medical advice despite having fever 
[21]. Further, in a German prospective study, only 34% of 
febrile travellers who received SBET in a pre-travel con-
sultation either sought medical care [16/167 (10%)] or 
took SBET [(40/167 (24%)] [22].
A recent study analysed 748 travellers to South and 
Southeast Asia with low or medium malaria transmis-
sion who had received SBET in a pre-travel consultation. 
Among the 100 febrile travellers carrying SBET during 
travel, only 14% took the correct measures (doctor visit 
or timely SBET administration) [23]. In the present study, 
the reasons for neither consulting nor performing the 
test were reasonable (diarrhoea and/or symptoms lasting 
a few hours only).
Interest of travellers for RDTs
For a period of 2  years, the interest of travellers to 
use RDTs was studied more precisely. One out of ten 
(11%) travellers were not interested to travel with 
RDT because they did not want to prick themselves 
or intended to rely on on-site health facilities. When 
asked upon return, most travellers (90%) who had trav-
elled with RDT were interested in taking RDT again 
for a future trip, mainly because they felt more secure. 
Those who did not want to mentioned that they 
would prefer to rely on on-site health facilities. These 
responses show that travellers have a good health 
judgment and that there is no ‘one size fits all’; every 
Table 2 Categories of travellers which were proposed RDT 
travel kits
a Despite visiting a high malaria risk area
b Between their routine medication (antidepressant and antiepileptic) and 
anti-malarials
Travellers’ category  
(multiple entries possible)
Total N = 691
n (%)
Long-term traveller (> 3 months) 478 (69%)
Traveller to remote areas 397 (57%)
Traveller’s request 117 (17%)
Health care professional 97 (14%)
Humanitarian worker 77 (11%)
Refusal to take  chemoprophylaxisa 68 (10%)
Short-stay frequent traveller 30 (4%)
Others 32 (5%)
 Travellers with children 12
 Pregnancy (known/desired) 8
 Expatriate 8
 Visiting friends and relatives (VFR) 2
 Fear of serious drug  interactionb 2
 Other reason, not specified 20
Table 3 Travellers’ reasons for  intending to  take or not take RDTs for  a future similar trip (open question analysed 
and categorized)
a But one would still take RDT if travelling with children
Reasons for taking RDT again (multiple entries possible)
Total N = 488
Reasons for NOT taking RDT again (multiple entries possible)
Total N = 55
220 “Reassuring” 9 “Good health infrastructures on-site”a
53 “To avoid unnecessary treatment” 7 “I am not at risk”, “I avoid risk areas”
28 “Especially useful when travelling with children” 5 “Prophylaxis will be enough”
11 “Convenient, practical” 5 “Useless”
8 “Help to react more quickly, autonomy” 4 “Protection against mosquito bites is enough”
1 “I will take prophylaxis and RDT, even in a low-risk area,  
because I already experienced malaria”
1 “Thought of being able to distinguish malaria symptoms from 
other origin”
167 No reason mentioned 24 No reason mentioned
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traveller chooses for themselves what they feel is most 
appropriate.
RDT performance by travellers
Only one traveller could not perform the training run 
because of shaking hands. During the trip, all travellers 
except two (who then reacted appropriately) managed 
to perform the test without problem, probably thanks 
to the training run done before departure. An untrained 
febrile peer in Southern Sudan, who had been given an 
RDT by a study participant, was not able to perform the 
test despite the illustrated instruction leaflet. The trained 
traveller repeated the test on his colleague without diffi-
culty and diagnosed malaria. This highlights the impor-
tance of performing a training run on oneself in good 
conditions before leaving, especially as it might be more 
challenging to perform the test once febrile (and espe-
cially amongst true malaria cases, as described by Jelinek 
[7]) or in a travelling environment.
In Jelinek’s prospective study assessing the use of dip-
stick RDTs among 98 European tourists consulting for 
fever in Kenya in 1998, 31% were unable to obtain a 
result. Among the 11 patients who had a microscopi-
cally confirmed malaria, 10 failed to diagnose them-
selves properly on-site [7]. In another study assessing 
self-testing for malaria in 153 symptomatic travellers 
returning from endemic areas, 18 did not want to be 
included because they were feeling too ill to concentrate, 
or they were not willing to prick themselves [8]. Lack of 
self-confidence can be overcome or at least minimized 
by training the traveller with performance of a practice 
run before departure, as done in this study. Reluctance 
to prick oneself was a reason not to provide the travel-
ler with RDT. In this study, the most difficult step of 
RDT performance observed during the training run was 
blood aspiration with the pipette. For this reason the 
pipette included in the ICT Combo  test® was changed 
for an inverted cup. Two of the 462 travellers who left 
with a pipette-containing kit reported difficulty transfer-
ring blood to the device in the field. Collecting blood and 
manipulating blood transfer devices were also difficul-
ties observed by Counihan et al. in assessing RDT use by 
community health workers with no medical background, 
which could be improved through training [10]. There-
fore, choosing an RDT brand with an easy-to-use blood 
transfer device, such as an inverted cup, is crucial for use 
by a lay person, especially when self-testing [24].
Interpretation of the RDT result
One traveller had difficulty reading the result because 
of a faint line appearing within 15  min. He took the 
SBET, as recommended in the written procedure in case 
of faint line. He mailed a picture of the test which was 
interpreted as a positive result. In a study assessing RDT 
use by community health workers in Zambia, Counihan 
et al. reported some difficulty reading faint positive test 
lines with the risk of interpreting as a negative result [10]. 
There is a positive correlation between line intensity and 
parasite density [11]; non-immune travellers at the begin-
ning of a malaria episode have thus a higher probability 
of having a faint line than patients living in endemic areas 
[18]. Since the traveller is instructed here to repeat the 
test in case of persistent fever, the second test is expected 
to show a stronger line due to increasing parasitaemia.
Action taken by travellers upon result of the test
Four travellers diagnosed themselves with malaria and all 
of them were able to start the SBET on time. They did not 
experience any adverse events. None of the negative trav-
ellers took SBET (but one received an antimalarial from 
a local clinic despite being tested negative again), which 
means that 47 unnecessary treatments could be avoided.
Incidence of malaria and choice of travellers’ categories 
for RDT provision
The overall incidence of malaria (case definition: fever 
and positive RDT) in these travellers was 0.03 per 100 
person-week (95% CI 0.0086–0.079), with an attack rate 
of 70/10,000 travellers. It was 0.07 per 100 person-week 
(185/10,000 travellers) in high and 0.02 per 100 person-
week (52/10,000 travellers) in moderate- to low-risk areas 
where the risk of malaria is reported to be lower than 
1/10,000 travellers [25]. The proportion of malaria was 4% 
among all fevers and 8% among fevers of more than a few 
hours. Even if the primary objective of this study was not 
to evaluate malaria incidence in travellers, the attack rate 
was much higher than expected; indeed, most of these 
travellers were visiting moderate- to low-risk endemic 
areas. These observations question the reliability of only 
estimating malaria incidence rate in travellers using 
denominators collected from tourist information at the 
macro-epidemiology level (national), as it has been done 
for Latin America and India for example—the incidence 
in UK travellers to Latin America was 0.8 per 10,000 visits 
with an average duration of stay of 18  days; in 2004 the 
estimated attack rate in French travellers to India was 
0.01% [26–29]—and applying uniform malaria prevention 
strategies to all persons travelling in a specific country.
Bottieau et  al. had already shown that P. falciparum 
malaria was more frequently diagnosed in expatri-
ates (38%), VFR travellers (36%) and foreign visitors or 
migrants (26%) than in Western travellers (14%) [30]. A 
common trait amongst these groups is that they usually 
stay a longer period in the visited endemic region and are 
poorly compliant to preventive strategies against malaria 
[16]. They should thus certainly be considered at higher 
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risk of exposure, even if they visit areas of low endemicity. 
Indeed, all positive cases in the present study were long-
term travellers. As already suggested by some experts [11, 
31], RDTs should be proposed to these categories of trav-
ellers, adding health care professionals and short-stay fre-
quent travellers. Young children and pregnant women are 
at particular risk of developing severe malaria [1]; RDT 
could be also be used in these categories as an additional 
tool of chemoprophylaxis. Although at high risk, VFRs 
were not proposed RDTs because it was assumed that 
they were more aware of how to access appropriate health 
care.
The present strategy for malaria prevention in travel-
lers is mainly based on the local level of malaria trans-
mission derived from national statistics, and from the 
attack rate in travellers estimated through tourist infor-
mation and imported malaria surveillance data [32–34]. 
The high malaria rates found in this cohort clearly shows 
that it is possible to better identify high risk groups dur-
ing the pre-travel consultation; not only because they 
travel in high transmission regions, but also because they 
have specific personal and travel characteristics. So ide-
ally, the malaria prevention recommendation should 
not only be geographically determined, but also tailored 
to an individual risk assessment. As this risk might be 
perceived and accepted differently from one traveller 
to the other, their preferences should also be taken into 
account [35]. In practice, high-risk category travellers for 
whom chemoprophylaxis is not indicated based on offi-
cial recommendations, or those who are unwilling to take 
chemoprophylaxis, should be proposed RDTs with SBET, 
as this is probably a safer strategy than providing SBET 
alone. Adding RDTs to the usual SBET strategy also has 
the advantage of informing the traveller of the possibil-
ity of having Plasmodium vivax infection (rather than, or 
as well as P. falciparum), which may allow them to make 
more appropriate treatment decisions, such as includ-
ing primaquine along with ACT. Another advantage of 
providing RDTs is that, when the result was negative, 
travellers could attend a health facility in search of an 
alternative cause for their fever: information that would 
likely also stimulate health workers to look for an alter-
native cause of the fever. This was suggested by the fact 
that travellers who subsequently attended on-site health 
facilities reported being diagnosed with gastroenteritis, 
amoebiasis, dengue, typhoid, pneumonia or urinary tract 
infection rather than empirically with malaria (except for 
one).
In addition, RDTs are now available on internet; only 4 
out of the 8 RDTs sold on internet in 2011 had both good 
sensitivity and specificity [36]. It is thus certainly a better 
strategy to provide good quality RDTs during a pre-travel 
consultation than leaving travellers to purchase them 
through internet without guidance.
Limitations
To prove that the provision of RDT and SBET is a perfectly 
safe strategy would have required a much larger sample 
size of travellers with fever. The same applies for demon-
strating that the results of the RDTs were always well inter-
preted. Although travellers were asked to send pictures of 
the test performed, only 4 out of 58 were received, and 2/4 
were from the positive cases. However, from the outcomes 
recorded, it is unlikely that malaria cases were missed, since 
none of the followed-up subjects developed malaria thereaf-
ter. Not all travellers meeting the criteria of the pre-defined 
categories were included, mostly due to time constraints of 
the consultation. This included travellers (especially fami-
lies), who already required many other types of pre-travel 
advice and vaccines. This is one of the reasons why VFRs 
were underrepresented, albeit that they are not one of the 
classic pre-defined high-risk target groups.
Conclusions
The vast majority of travellers provided with malaria RDTs 
used them according to the practical, oral and written 
instructions received during the pre-travel consultation. 
A fifth of febrile travellers neither performed the test nor 
consulted a health facility because the fever episode only 
lasted a few hours. Four travellers were able to self-diag-
nose and treat malaria adequately, which revealed a much 
higher incidence of malaria than expected. This strategy of 
RDT with SBET made the travellers feel more secure and 
allowed prompt treatment for malaria in high-risk groups. 
It has the additional advantage to avoid over-diagnosis of 
malaria and inappropriate on-site treatment. To ensure 
the success of this strategy, two key elements should be 
integrated in pre-travel consultations: (1) guiding travel-
lers through a full training run to perform and interpret 
the RDT using their own blood; and (2) targeting travel-
lers at higher risk of getting malaria. Thus, proposing pre-
emptive RDTs in travel clinics may be a safe and effective 
option to better tailor malaria prevention to suit the indi-
vidual needs and wishes of selected travellers, allowing 
them to make informed decisions on early treatment.
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